Evidence map›Paper›PMID 19136942›Full record

ArticleCell death and differentiation2009

TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL.

L C Spender, D I O'Brien, D Simpson, D Dutt, C D Gregory, M J Allday, L J Clark, G J Inman

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 88 citations in OpenAlex.

  1. SMURF2 in Anticancer Therapy: Dual Role in Carcinogenesis and Theranostics.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Recent development of oral vaccines (Review).Experimental and therapeutic medicine · 2024
    Review
  6. TGF-β signaling in health, disease, and therapeutics.Signal transduction and targeted therapy · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Long-TermMicroorganisms · 2020
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

L C SpenderGrowth Factor Signalling Laboratory, The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow, UK. l.spender@beatson.gla.ac.uk
D I O'Brien
D Simpson
D Dutt
C D Gregory
M J Allday
L J Clark
G J Inman
Cancer Research UK Scotland Institute · GBCentre for Inflammation Research · GBImperial College London · GBSouthern General Hospital · GBStobhill Hospital · GB

Funding

Cancer Research UK A4252Worldwide Cancer Research 03-0900
6 · The paper itself

Abstract

Transforming growth factor-beta (TGF-beta) potently induces apoptosis in Burkitt's lymphoma (BL) cell lines and in explanted primary human B lymphocytes. The physiological relevance and mechanism of TGF-beta-mediated apoptosis induction in these cells remains to be determined. Here we demonstrate the requirement for TGF-beta-mediated regulation of BIK and BCL-X(L) to activate an intrinsic apoptotic pathway in centroblastic BL cells. TGF-beta directly induced transcription of BIK and a consensus Smad-binding element identified in the BIK promoter recruits TGF-beta-activated Smad transcription factor complexes in vivo. TGF-beta also transcriptionally repressed expression of the apoptosis inhibitor BCL-X(L). Inhibition of BCL-X(L) sensitised BL cells to TGF-beta-induced apoptosis whereas overexpression of BCL-X(L) or suppression of BIK by shRNA, diminished TGF-beta-induced apoptosis. BIK and BCL-X(L) were also identified as TGF-beta target genes in purified normal human centroblast B cells and immunohistochemical analyses of tonsil tissue revealed widespread TGF-beta receptor-regulated Smad activation and a focal pattern of BIK expression. Furthermore, using a selective inhibitor of the TGF-beta receptor we provide evidence that autocrine TGF-beta signalling through ALK5 contributes to the default apoptotic programme in normal human centroblasts undergoing spontaneous apoptosis. Our data suggests that TGF-beta may act as a physiological mediator of human germinal centre homoeostasis by regulation of BIK and BCL-X(L).

Indexed as

ApoptosisApoptosis Regulatory Proteinsbcl-X ProteinB-LymphocytesCell Line, TumorCells, CulturedElectrophoretic Mobility Shift AssayFlow CytometryGene Expression RegulationHumansImmunoblottingImmunohistochemistryIn Vitro TechniquesMembrane ProteinsMitochondrial ProteinsReverse Transcriptase Polymerase Chain ReactionApoptosis Regulatory Proteinsbcl-X ProteinBIK protein, humanMembrane ProteinsMitochondrial ProteinsTransforming Growth Factor beta

Identifiers

PMID19136942
PMCPMC2857326
OpenAlexW2161035805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.